Serial Assessment of AI-Based Body Composition Change After 18 Months of Evolocumab Treatment: An EVOLVE Subanalysis (AHA 2026) - Sep 5, 2026 - Abstract #MDP0601; Pres time: Nov 7, 2026; 12:43 PM - 12:48 PM; Location: Moderated Digital Poster 6, Clinical Science Zone 1; "Abstract is embargoed at this time."
|
|
Donghee Han, Cedars-Sinai Medical Ctr, West Hollywood, CA; Aakash Shanbhag, Cedars Sinai Medical Ctr, San Pedro, CA; Jirong Yi, Cedars-Sinai Medical Ctr, Los Angeles, CA; Evangelos Tzolos, Cedars-Sinai Medical Ctr, Edinburgh, United Kingdom; Rebekah Park, Heidi Gransar, Cedars-Sinai Medical Ctr, Los Angeles, CA; Mark Lemley, Cedars Sinai, Springfield, OR; Hyun Mark, John Friedman, Sean Wallace Hayes, Cedars-Sinai Medical Ctr, Los Angeles, CA; louise elizabeth jane thomson, Cedars Sinai Medical Ctr, Los Angeles, CA; Alan C Kwan, Cedars-Sinai Medical Ctr, Los Angeles, CA; Matthew J Budoff, Lundquist Inst, Torrance, CA; Prediman K Shah, Cedars Sinai Medical Ctr, Los Angeles, CA; Jacek Kwiecinski, Cedars-Sinai Medical Ctr, Wejherowo, Poland; Damini Dey, Cedars-Sinai Medical Ctr, Los Angeles, CA; Balaji Tamarappoo, Mayo Clinic, Phoenix, AZ; Daniel Berman, Cedars-Sinai Medical Ctr, Los Angeles, CA; Piotr Jan Slomka, Cedars-Sinai Medical Ctr, W Hollywood, CA
|